Header Logo

Connection

JONATHAN LEI to Paclitaxel

Back to Details
This is a "connection" page, showing publications JONATHAN LEI has written about Paclitaxel.
JONATHAN LEI
Connection Strength
0.222
Paclitaxel
  1. Phase 2 study of neoadjuvant enzalutamide and paclitaxel for luminal androgen receptor-enriched TNBC: Trial results and insights into "ARness". Cell Rep Med. 2024 Jun 18; 5(6):101595.
    View in: PubMed
    Score: 0.222
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.